Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Net income as a percentage of revenue
3Y CAGR
+17.3%/yr
vs +22.0%/yr prior
5Y CAGR
-15.5%/yr
Recent acceleration
Acceleration
-4.8pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 16.73% | +15.5% |
| 2024 | 14.49% | +9.5% |
| 2023 | 13.23% | +27.5% |
| 2022 | 10.38% | +31.3% |
| 2021 | 7.90% | -79.7% |
| 2020 | 38.94% | +729.5% |
| 2019 | 4.69% | +0.3% |
| 2018 | 4.68% | +105.3% |
| 2017 | -88.19% | +90.6% |
| 2016 | -940.60% | - |